Cargando…
Electroporation (EP)-related technical errors experienced during an HIV vaccine clinical trial conducted in Rwanda and Uganda: lessons learned
Autores principales: | Bayingana, R, Nanvubya, A, Karita, E, Nyombayire, J, Ingabire, R, Chinyenze, K, Lehrman, J, Schimidt, C, Hannaman, D, Allen, S, Fast, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441335/ http://dx.doi.org/10.1186/1742-4690-9-S2-P113 |
Ejemplares similares
-
Tolerability and acceptability of electroporation during a Phase 1 vaccine trial at two sites in Uganda and Rwanda
por: Mpendo, J, et al.
Publicado: (2012) -
Sexual behavior among volunteers enrolled in a Phase I HIV vaccine trial: experience of Projet San Francisco in Kigali, Rwanda
por: Mukamuyango, J, et al.
Publicado: (2012) -
A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults
por: Mpendo, Juliet, et al.
Publicado: (2015) -
Acceptability and tolerability of repeated intramuscular electroporation of Multi-antigenic HIV (HIVMAG) DNA vaccine among healthy African participants in a phase 1 randomized controlled trial
por: Mpendo, Juliet, et al.
Publicado: (2020) -
Community health worker promotions increase uptake of long-acting reversible contraception in Rwanda
por: Mazzei, Amelia, et al.
Publicado: (2019)